These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8659280)

  • 41. Urodynamic pressure flow studies can predict the clinical outcome after transurethral prostatic resection.
    Rodrigues P; Lucon AM; Freire GC; Arap S
    J Urol; 2001 Feb; 165(2):499-502. PubMed ID: 11176404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.
    Lukacs B; Leplège A; Thibault P; Jardin A
    Urology; 1996 Nov; 48(5):731-40. PubMed ID: 8911517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of transurethral resection of the prostate in the patients with weak bladder contractility index.
    Han DH; Jeong YS; Choo MS; Lee KS
    Urology; 2008 Apr; 71(4):657-61. PubMed ID: 18313105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term follow-up of interstitial laser coagulation in the treatment of benign prostatic hyperplasia].
    Knoll T; Michel MS; Trojan L; Bross S; Alken P; Köhrmann KU
    Aktuelle Urol; 2003 Jan; 34(1):48-51. PubMed ID: 14566701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Change in International Prostate Symptom Score after transurethral prostatectomy in Taiwanese men with benign prostate hyperplasia: use of these changes to predict the outcome.
    Chuang FP; Lee SS; Wu ST; Yu DS; Chen HI; Chang SY; Sun GH
    Arch Androl; 2003; 49(2):129-37. PubMed ID: 12623749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of international prostate symptom scoring system in the management of BPH in Jos, Nigeria.
    Amu OC; Udeh EI; Ugochukwu AI; Dakum NK; Ramyil VM
    Niger J Clin Pract; 2013; 16(3):273-8. PubMed ID: 23771445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problems with administration of international prostate symptom score in a developing community.
    Ogwuche EI; Dakum NK; Amu CO; Dung ED; Udeh E; Ramyil VM
    Ann Afr Med; 2013; 12(3):171-3. PubMed ID: 24005590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptom severity and patients' values in the decision to perform a transurethral resection of the prostate.
    Krumins PE; Fihn SD; Kent DL
    Med Decis Making; 1988; 8(1):1-8. PubMed ID: 2448577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptom status and quality of life following prostatectomy.
    Fowler FJ; Wennberg JE; Timothy RP; Barry MJ; Mulley AG; Hanley D
    JAMA; 1988 May; 259(20):3018-22. PubMed ID: 2452905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International variation in intervention rates. What are the implications for patient selection?
    Black N; Glickman ME; Ding J; Flood AB
    Int J Technol Assess Health Care; 1995; 11(4):719-32. PubMed ID: 8567204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative population-based survey as evaluation method of prostate disease changes].
    Resel Estévez L; Rodríguez Vallejo JM; Conejero Sugrañes J; Jiménez Cruz F; Rioja Sanz LA; Vela Navarrete R; Vicente Rodríguez J; Esteban Fuertes M
    Actas Urol Esp; 1999 Sep; 23(8):657-69. PubMed ID: 10584343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.
    Wadhwa K; Carmona-Echeveria L; Kuru T; Gaziev G; Serrao E; Parashar D; Frey J; Dimov I; Seidenader J; Acher P; Muir G; Doble A; Gnanapragasam V; Hadaschik B; Kastner C
    Asian J Androl; 2017; 19(1):62-66. PubMed ID: 26924279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions.
    Batista-Miranda JE; Diez MD; Bertrán PA; Villavicencio H
    Pharmacoeconomics; 2001; 19(11):1079-90. PubMed ID: 11735675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR; Agrawal CS
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia].
    Luján Galán M; Páez Borda A; Martín Osés E; Llanes González L; Berenguer Sánchez A
    Arch Esp Urol; 1997 Oct; 50(8):847-53. PubMed ID: 9463282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate?
    Hakenberg OW; Pinnock CB; Marshall VR
    J Urol; 1997 Jul; 158(1):94-9. PubMed ID: 9186331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of the IPSS questionnaire in surgical patients. International Prostatic Symptom Score].
    Batista-Miranda JE; Regalado Pareja R; Huguet Pérez J; Montlleo Sánchez M; Araño Bertran P
    Actas Urol Esp; 1995 Mar; 19(3):227-33. PubMed ID: 8659280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
    Zhao Z; Wang G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.